5,175 drugs to be re-evaluated in 2013

Published: 2012-09-04 06:59:00

Updated: 2012-09-04 06:59:00

The Korea Food and Drug Administration announced last Friday that a total of 5,175 products acting on nervous system will be re-evaluated next year as a regular program to assess their safety and efficacy.

The drugs from eight therapeutic categories include general anesthetics, hypnosedatives, anti-epileptics, antipyretics, analgesics & an-inflammatory agents, analeptic stimulants, antiverti...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.